Hello CAN! We are exploring an institutional policy for capital equipment purchase that would govern all instruments/equipment. We currently have a system in place where all institutional funded purchases are reviewed, with a strong prejudice for placement in the cores. Recently we have seen a spate of instruments purchased with other funding for individual clinical research labs. Aside from impacting the cores business, this is also impacting data quality, research rigor and space usage. Would any of you have an institutional capital purchase policy that encompasses all capital equipment that you could share? Thanks in advance, Sheenah <email obscured>)